by Salomi LBSP | Jun 3, 2025 | News
Leyden Labs has secured €20 million in financing from the European Investment Bank (EIB), supported by HERA Invest under the EU’s InvestEU programme. The funding will support the clinical development of Leyden Labs’ PanFlu nasal spray, an intranasal antibody therapy...
by Salomi LBSP | Jun 2, 2025 | News
Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine targeting non-small cell lung cancer (NSCLC). This vaccine aims to expose cancer cells that have evaded the immune system,...
by Salomi LBSP | May 30, 2025 | News
Leiden University Medical Center (LUMC) has achieved a national milestone by treating the first Dutch patient with an autoimmune disease using CAR-T cell therapy. This approach, previously reserved for cancer treatment, was applied to a patient with severe...
by Salomi LBSP | May 28, 2025 | News
TNO and FAST (Financiering en Acceleratie voor Therapieontwikkeling) have launched a strategic collaboration to accelerate the development of advanced therapies, including ATMPs, radiopharmaceuticals, treatments for rare diseases, infectious diseases, and drug...
by Salomi LBSP | May 22, 2025 | News
Leiden University Medical Center (LUMC) has successfully implemented artificial intelligence (AI) to optimize radiotherapy planning for patients with head and neck cancer. This has led to significant time savings and improved protection of healthy tissues during...